Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors

ACS Medicinal Chemistry Letters
2013.0

Abstract

Matriptase belongs to trypsin-like serine proteases involved in matrix remodeling/degradation, growth regulation, survival, motility, and cell morphogenesis. Herein, we report a structure-based approach, which led to the discovery of sulfonamide and amide derivatives of pyridyl bis(oxy)benzamidine as potent and selective matriptase inhibitors. Co-crystal structures of selected compounds in complex with matriptase supported compound designing. Additionally, WaterMap analyses indicated the possibility of occupying a distinct pocket within the catalytic domain, exploration of which resulted in >100-fold improvement in potency. Co-crystal structure of 10 with matriptase revealed critical interactions leading to potent target inhibition and selectivity against other serine proteases.

Knowledge Graph

Similar Paper

Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors
ACS Medicinal Chemistry Letters 2013.0
Structure-Based Approach for the Discovery of Bis-benzamidines as Novel Inhibitors of Matriptase
Journal of Medicinal Chemistry 2001.0
Identification of the First Low-Molecular-Weight Inhibitors of Matriptase-2
Journal of Medicinal Chemistry 2010.0
Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis
Bioorganic & Medicinal Chemistry Letters 2015.0
Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome
Bioorganic & Medicinal Chemistry Letters 2005.0
Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer
Marine Drugs 2017.0
Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer
Marine Drugs 2017.0
Structural studies of Enterococcus faecalis methionine aminopeptidase and design of microbe specific 2,2′-bipyridine based inhibitors
MedChemComm 2012.0
Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal–epithelial transition factor (c-Met) protein kinase
Bioorganic & Medicinal Chemistry 2016.0
Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design
Journal of Medicinal Chemistry 2016.0